Radiation Oncology Team

	Richard Tuli, MD Medical Director, Radiation Oncology, Tampa General Hospital Deputy Director, TGH Cancer Institute Richard Tuli, MD, PhD, is the director of radiation oncology at Tampa General Hospital as well as a professor and chair of radiation oncology at USF Health Morsani College of Medicine. Prior to joining TGH, he served as associate attending and director of developmental therapeutics at the NCI-designated comprehensive cancer center, Memorial Sloan Kettering Cancer Center in New York, and associate professor and clinical director of radiation oncology at Cedars-Sinai Medical Center in Los Angeles. As a leader in advancing the field of radiation oncology, Dr. Tuli focuses on providing a comprehensive, multi-disciplinary and personalized experience for patients through a combination of cutting-edge technology, novel treatments and developing a connection between the patient and provider.
	Clayton Alonso, MD Radiation Oncologist, TGH Cancer Institute Dr. Clayton Elliott Alonso is a highly accomplished radiation oncologist. Prior to joining Tampa General Hospital, he served since 2019 at Advanced Cancer Treatment Centers in Brooksville, Florida. Dr. Alonso’s journey began with his education at the University of Virginia School of Medicine, where he graduated with honors and was inducted into the prestigious Alpha Omega Alpha honor society. He completed his transitional year at the University of Pittsburgh Medical Center Mercy in 2015, before embarking on his residency in Radiation Oncology at the University of Virginia School of Medicine, where he was recognized as Chief Resident from 2018 to 2019. During his residency, Dr. Alonso received several accolades, including the Constable/Agarwal Award and the Clinical Excellence Award, highlighting his dedication and exceptional performance in the field.
	Brian T. Collins, MD, FCCP Radiation Oncologist, TGH Cancer Institute Dr. Brian T. Collins is a board-certified radiation oncologist with significant clinical experience in treating brain, breast and lung cancers. Regarded as a world-renowned expert in CyberKnife® radiotherapy technology, Dr. Collins specializes in cutting-edge radiation oncology techniques and tools. Dr. Collins has frequently contributed to scientific journals, books and publications in areas of his expertise. He is a Fellow in the American College of Chest Physicians (ACCP) and a member of numerous related professional organizations.
	Sean P. Collins, MD, FCCP Radiation Oncologist, TGH Cancer Institute Vice Chair, Faculty Affairs Dr. Sean P. Collins is a highly accomplished radiation oncologist, most recently serving as the director of the CyberKnife Prostate Program at MedStar Georgetown University Hospital in Washington, D.C. With board certification from the American Board of Radiology in Radiation Oncology, Dr. Collins has dedicated over two decades to advancing the treatment of prostate cancer. Specifically, he has treated over 2500 men with prostate cancer utilizing the CyberKnife. He has been at the forefront of innovative radiation therapies, earning him recognition as a Washingtonian Top Doctor since 2015.
	Rodney Ellis, MD Radiation Oncologist, TGH Cancer Institute Vice Chair, Radiation Oncology Operations Dr. Rodney Ellis is a distinguished Radiation Oncologist specializing in adult malignancies, with a focus on genitourinary cancers like prostate, bladder, and renal cancer. He earned his Medical Doctor Degree from Northeast Ohio Medical University. Dr. Ellis has held faculty positions as Associate and later Professor in Radiation Oncology, Urology, and Radiology at Case Western Reserve University. He also held the esteemed position of Inaugural Chair of the Department of Radiation Oncology for the Penn State University/Penn State Cancer Institute and the Milton Hershey Medical Center, making significant contributions to the Penn State Health Cancer Network.
	Craig E. Grossman, MD, PhD, MSCE Radiation Oncologist, TGH Cancer Institute Dr. Craig E. Grossman is a radiation oncologist at Tampa General Hospital (TGH). Before coming to TGH, Dr. Grossman accumulated an extensive range of professional and academic experiences. Most recently, he served as an Assistant Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center in New York, and and trained radiation therapists and dosimetrists as a Clinical Assistant Professor in the School of Health Technology and Management at Stony Brook University in Stony Brook, New York. Dr. Grossman has shared his expertise on a variety of radiation oncology topics through lectures at international meetings, hospitals and universities, and in the community. He has also contributed to the development of innovative radiation treatments, as well as published national guidelines related to genitourinary cancer (i.e. prostate, bladder, testicular) and gynecology cancer (i.e. endometrial, cervix, vagina, vulva) management. He is an expert in the treatment of prostate cancer with brachytherapy and stereotactic body radiotherapy (SBRT) among other treatment modalities, as well as treating women with various radiation techniques for their gynecologic cancer. Dr. Grossman has both clinical and research interests in sexual medicine, minimizing radiation-related side effects, and new technologies to treat cancer to improve cure rates.
	Mohamed Khattab, MD Radiation Oncologist, TGH Cancer Institute Dr. Mohamed Khattab is a radiation oncologist at Tampa General Hospital and a faculty member at the USF Health Morsani College of Medicine. Dr. Khattab specializes in treating patients with brain and spine tumors and has a unique expertise in the treatment of benign neuropsychiatric diseases and complex pain syndromes using stereotactic radiosurgery. After earning his medical degree from the Johns Hopkins School of Medicine, he began his training in neurosurgery at New York University before transitioning to radiation oncology at Vanderbilt University, where he served as chief resident.
	Heyoung McBride, MD, MS Radiation Oncologist, TGH Cancer Institute Dr. Heyoung L. McBride is a board-certified radiation oncologist with expertise in brachytherapy and stereotactic radiosurgery. She earned her medical degree from The University of Kansas School of Medicine, completed her residency at the University of Arizona Health Sciences Center and was an ASTRO Research Fellow at the University of Arizona Cancer Center. Most recently, Dr. McBride served as co-medical director of Lovelace Cancer Center and medical director of Radiation Oncology at Lovelace Health System, while also having held a faculty position as clinical associate professor at the University of Arizona College of Medicine Phoenix.
	Alexander Engelman, MD Radiation Oncologist, TGH Cancer Institute Dr. Alexander Engelman, a native of Tampa, is a radiation oncologist with knowledge treating all cancer sites. He has experience with advanced treatments including external beam radiotherapy, brachytherapy, partial breast irradiation, Gamma Knife and CyberKnife radiosurgery, and stereotactic body radiotherapy. Dr. Engelman is a graduate of the Georgetown University School of Medicine. For residency training, he attended the University of Maryland Medical Center and the Maryland Proton Treatment Center with additional time at St. Jude Children’s Research Hospital.
	Nirav Patel, MD Radiation Oncologist, TGH Cancer Institute Dr. Nirav Patel is a board-certified Radiation Oncologist committed to providing exceptional care to patients in their fight against cancer. Dr. Patel completed his undergraduate studies and medical school at the prestigious University of Virginia. He then received comprehensive residency training at the University of Miami, where he had the honor of serving as chief resident. He has experience in treating a wide range of cancers with expertise in using advanced techniques, including external beam radiation therapy, stereotactic body radiation therapy, stereotactic radiosurgery, brachytherapy, as well as proton therapy. During his residency, he completed an externship at the world-renowned Memorial Sloan Kettering Cancer Center in New York, where he gained additional experience with brachytherapy as a treatment modality for prostate cancer.